Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003157	mm-hygvi	— (—)	106	695	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

False labour

10.74

26.91

6.1

7.0

—

Delivery, wide proxy

+∞

16.00

7.3

0.0

—

Maternal care for other known or suspected fetal problems

7.48

14.14

5.6

7.3

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

6.93

13.43

6.9

7.0

—

Pregnancy, childbirth and the puerperium

+∞

10.32

6.1

0.0

—

Complications of labour and delivery

4.01

9.28

9.1

4.7

—

Other maternal disorders predominantly related to pregnancy

3.86

8.70

5.6

7.2

—

Diabetes mellitus in pregnancy

3.73

7.82

5.4

7.3

—

Maternal care for known or suspected abnormality of pelvic organs

6.40

6.83

7.8

7.2

—

Maternal care for known or suspected malpresentation of fetus

6.39

6.55

7.2

—

Labour and delivery complicated by fetal stress [distress]

3.67

6.33

7.4

4.9

—

Premature rupture of membranes

5.77

6.12

6.8

7.3

—

Other obstetric conditions, not elsewhere classified

2.80

5.86

7.4

6.5

—

Other disorders of amniotic fluid and membranes

6.11

4.93

5.4

7.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.61

4.89

7.7

6.5

—

Prolonged pregnancy

5.39

4.44

6.9

7.2

—

Persons with potential health hazards related to communicable diseases

2.66

4.32

7.2

6.4

—

Postpartum haemorrhage

3.30

4.32

9.1

4.9

—

Gestational diabetes (for exclusion)

2.48

4.25

5.7

7.1

—

Perineal laceration during delivery

3.23

4.16

8.4

4.9

—

Complications predominantly related to the puerperium

2.77

3.84

6.3

7.2

—

Other nutritional deficiencies

2.45

3.65

5.0

7.1

—

Contact with and exposure to communicable diseases

2.49

3.50

7.7

6.5

—

Tramadol

0.00

3.45

0.0

7.5

—

Infections of breast associated with childbirth

7.02

3.36

8.1

6.5

—

Spontaneous abortion

2.47

3.32

6.4

6.9

—

Maternal care for known or suspected fetal abnormality and damage

4.46

3.29

9.9

7.2

—

Diabetes, insulin treatment (Kela reimbursement)

0.00

3.28

0.0

7.8

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.00

3.26

0.0

7.6

—

ILD medications: immunosuppressive drugs

0.00

3.13

0.0

6.9

—

Preterm labour and delivery

4.00

3.08

8.9

4.7

—

Placenta praevia

7.52

3.05

7.0

8.3

—

Gestational [pregnancy-induced] hypertension

2.58

3.02

6.1

7.0

—

Intestinal infectious diseases

2.17

2.99

5.5

6.9

—

Obstructed labour due to malposition and malpresentation of fetus

3.27

2.92

7.6

4.5

—

Obesity

2.24

2.66

4.2

7.3

—

Obesity and other hyperalimentation

2.23

2.65

4.2

7.3

—

Obesity due to excess calories

2.33

2.64

4.3

7.4

—

Haemorrhage in early pregnancy

2.91

2.59

5.2

7.6

—

ILD medications

100

0.32

2.53

8.2

6.5

—

Abnormal findings on antenatal screening of mother

3.23

2.51

6.0

7.7

—

Poor fetal growth

2.55

2.44

5.5

7.1

—

L04AX Other immunosuppressants

0.00

2.24

0.0

7.3

—

Superficial injury of forearm

3.69

2.15

4.6

6.6

—

First line medication for Crohn's disease

0.38

2.14

9.1

6.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

0.35

2.12

8.2

6.6

—

Reimbursement for rheumatic diseases

0.00

2.06

0.0

7.5

—

Inflammatory bowel disease treatment related agents

0.39

2.00

9.1

6.4

—

Long labour

2.52

1.97

7.9

4.7

—

Examination and observation for other reasons

2.32

1.94

8.3

6.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.98

1.89

5.7

6.8

—

Female infertility, cervical, vaginal, other or unspecified origin

2.09

1.83

8.8

6.8

—

Twin gestation

4.17

1.82

5.4

8.3

—

Multiple gestation

4.17

1.82

5.4

8.3

—

Benzodiazepine use

0.35

1.79

9.0

6.5

—

Pregnancy with abortive outcome

1.82

1.73

5.7

6.8

—

Pre-eclampsia or poor fetal growth

2.02

1.72

5.9

6.9

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.83

1.72

8.9

6.6

—

Cough

0.00

1.71

0.0

6.6

—

Chronic rhinitis, nasopharyngitis and pharyngitis

0.00

1.69

0.0

7.9

—

Pregnancy hypertension

1.92

1.69

5.8

6.8

—

Postpartum hemorraghe, all women as controls

1.95

1.68

9.1

6.3

—

Melanocytic naevi

0.00

1.68

0.0

7.5

—

Benign neoplasms

0.44

1.66

7.5

6.5

—

Oral corticosteroids

0.40

1.58

8.2

6.6

—

Failed induction of labour

3.00

1.58

7.2

4.7

—

Any event in cancer register

0.37

1.55

9.2

6.8

—

Peritonsillar abscess

0.00

1.51

0.0

8.3

—

Atopic dermatitis

1.81

1.50

6.3

6.8

—

Maternal care for other conditions predominantly related to pregnancy

2.22

1.44

7.5

7.3

—

Effects of foreign body entering through natural orifice

2.73

1.43

4.0

8.0

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1.76

1.41

7.2

6.6

—

Dislocation, sprain and strain of joints and ligaments at neck level

2.42

1.39

7.0

8.5

—

Arthrosis

0.00

1.38

0.0

6.5

—

Neoplasms

0.50

1.36

5.3

6.5

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

1.34

0.0

7.7

—

Emotionally unstable personality disorder

0.00

1.33

0.0

7.7

—

Other complications of labour and delivery, not elsewhere classified

2.16

1.33

4.8

4.7

—

Persons encountering health services for specific procedures and health care

0.50

1.30

5.9

6.7

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.78

1.28

7.0

7.2

—

Psychiatric diseases

0.45

1.24

6.7

6.8

—

Uterine polyps

0.00

1.20

0.0

7.1

—

Cardiovascular diseases (excluding rheumatic etc)

0.50

1.19

3.3

7.0

—

Urinary track infection

1.62

1.19

4.8

7.8

—

Non-invasive ventilation

0.00

1.17

0.0

8.9

—

Disorders of psychological development

0.00

1.16

0.0

7.8

—

Acne vulgaris

0.00

1.16

0.0

7.8

—

Adverse effects, not elsewhere classified

0.00

1.16

0.0

8.8

—

Bacterial infection, other or unspecified, including avohilmo

0.00

1.15

0.0

7.6

—

Other bacterial intestinal infections, including avohilmo

2.50

1.15

10.4

6.6

—

Injuries to the neck

2.05

1.15

6.8

7.6

—

LSIL lesion of the cervix uteri

0.00

1.15

0.0

7.8

—

Anxiety (asthma-related co-morbidities)

0.44

1.15

7.0

6.6

—

All anxiety disorders

0.44

1.14

7.0

—

Diseases of oesophagus, stomach and duodenum

0.50

1.14

3.4

7.1

—

Exclusions for E4_PCOS_CONSORTIUM

0.49

1.13

5.1

6.8

—

Acute bronchitis

2.01

1.12

4.4

8.2

—

Conjunctivitis (acute, non atopic), including avohilmo

1.64

1.12

6.8

6.2

—

Other diseases of lip and oral mucosa

2.00

1.12

8.6

7.6

—

Other heart diseases, wide

0.48

1.09

5.3

7.2

—

Type of accident

2.19

1.08

6.3

8.1

—

Dermatitis and eczema

1.57

1.07

6.6

6.8

—

Other diseases of urinary system

1.57

1.05

4.6

7.6

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.12

1.05

6.3

8.2

—

Cystitis

1.59

1.05

4.3

7.6

—

Implicit viral Sepsis, including avohilmo

2.27

1.03

6.8

8.0

—

Acne, including avohilmo

0.46

1.02

4.8

6.9

—

Female infertility

1.70

1.01

8.1

6.7

—

Viral and other specified intestinal infections

1.87

1.00

7.9

7.4

—

Any mental disorder

0.53

0.98

7.1

6.8

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.17

0.98

7.4

7.1

—

All influenza

2.17

0.98

7.0

7.8

—

Sulfasalazine

0.00

0.97

0.0

7.7

—

Other problems related to primary support group, including family circumstances

0.00

0.96

0.0

8.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

0.50

0.96

12.3

6.6

—

Diseases of the digestive system

0.00

0.96

0.0

7.9

—

Speech and linguistic disorders, excluding more controls

0.00

0.95

0.0

7.4

—

Amenorrhoea

0.00

0.95

0.0

7.6

—

Type 1 diabetes

0.00

0.95

0.0

7.8

—

Autoimmune diseases excluding thyroid diseases

0.57

0.93

6.0

6.6

—

Intracranial injury

1.72

0.92

7.1

—

Dyspnoea

0.49

0.91

7.0

7.1

—

Injuries to the elbow and forearm

1.61

0.90

8.3

6.3

—

Headache

1.61

0.89

5.9

6.8

—

Impacted maxillary molar

2.07

0.89

6.3

7.4

—

Personal history of other diseases and conditions

2.06

0.89

9.5

7.1

—

Temporomandibular joint disorders, including avohilmo

101

0.48

0.88

3.8

6.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

0.58

0.82

6.0

6.4

—

Disorders of lipoprotein metabolism and other lipidaemias

0.00

0.82

0.0

5.5

—

Bacterial infection, other or unspecified

0.00

0.80

0.0

7.3

—

Speech and linguistic disorders

0.00

0.79

0.0

8.2

—

Biological medication for rheuma

0.00

0.79

0.0

6.9

—

Fracture of shoulder and upper arm

0.00

0.79

0.0

7.8

—

Acute sinusitis

1.60

0.78

7.8

6.9

—

Diseases of appendix

0.52

0.78

3.6

7.0

—

Other noninfective gastroenteritis and colitis

0.00

0.78

0.0

8.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.56

0.78

3.0

6.9

—

Other antidepressants

0.58

0.77

6.4

6.2

—

Excessive attrition of teeth

0.50

0.77

4.0

6.7

—

Type 1 diabetes, wide definition, subgroup 1

0.00

0.77

0.0

7.1

—

Type 1 diabetes, wide definition

0.00

0.77

0.0

7.1

—

Sub-endpoint used in defining T1D endpoints

0.00

0.77

0.0

6.8

—

Pneumonias (Asthma/COPD co-morbidities)

0.59

0.75

4.4

6.9

—

All pneumoniae

0.59

0.75

4.4

6.9

—

Any reimbursement code in KELA

0.61

0.75

10.5

6.0

—

Infections of genitourinary tract in pregnancy

2.08

0.74

5.0

9.0

—

Postpartum hemorraghe, parous women as controls

1.49

0.72

9.1

6.1

—

Autoimmune diseases related-to ILD

0.54

0.72

9.3

6.5

—

Sleep apnoea, including avohilmo

0.53

0.69

4.8

7.8

—

Viral and other specified intestinal infections, including avohilmo

1.60

0.69

7.3

7.0

—

Codeine or tramadol medication

0.64

0.69

5.0

6.8

—

Other diseases of intestines

0.64

0.68

6.5

6.6

—

Internal derangement of knee

1.65

0.67

6.0

7.7

—

Dorsopathies

1.39

0.67

4.7

7.2

—

Fracture of forearm

1.63

0.66

10.3

6.7

—

Appendicitis, broad definition

0.52

0.66

3.6

7.0

—

Tonsillectomy and adenotomy

0.62

0.65

4.5

6.9

—

Other inflammation of eyelid, including avohilmo

1.54

0.65

7.4

7.0

—

Codeine

0.65

0.64

5.0

6.9

—

Diseases of the skin and subcutaneous tissue

1.43

0.64

6.4

7.3

—

Cutaneous abscess, furuncle and carbuncle

1.72

0.64

3.0

9.0

—

Caries of enamel

1.42

0.62

8.8

5.9

—

Oxicams

0.00

0.62

0.0

8.8

—

General symptoms and signs

1.39

0.62

6.0

6.8

—

Polycystic ovarian syndrome, consortium definition

0.66

0.61

5.4

6.7

—

Rheumatoid arthritis

0.00

0.61

0.0

6.6

—

Abnormal findings on examination of blood, without diagnosis

0.00

0.60

0.0

6.6

—

Septicaemia

0.00

0.60

0.0

7.2

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

0.00

0.60

0.0

6.5

—

Hypertrophy of breast

0.00

0.60

0.0

6.6

—

Hypertrophy of breast in women and men

0.00

0.60

0.0

6.7

—

Rheumatoid arthritis, including avohilmo

0.00

0.60

0.0

6.9

—

Substance use, excluding alcohol

0.00

0.60

0.0

6.7

—

Other and unspecified mood [affective] disorders

0.00

0.59

0.0

8.4

—

Alcohol abuse, main dg, excluding more controls

0.00

0.59

0.0

7.9

—

Triptan medication for migraine, single purchase ok

1.40

0.59

6.6

6.4

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.40

0.59

6.6

6.4

—

Tumor necrosis factor alpha inhibitors

0.00

0.58

0.0

6.9

—

Diseases of oral cavity, salivary glands and jaws

1.72

0.58

8.0

6.3

—

Transport accidents

1.57

0.58

7.9

6.5

—

Nerve, nerve root and plexus disorders

0.64

0.56

6.0

6.8

—

Mood disorders, excluding more controls

0.63

0.56

5.5

6.8

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.57

0.56

14.2

6.2

—

Polycystic ovarian syndrome, broad definition

1.46

0.56

5.9

7.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.63

0.56

4.4

7.1

—

Female infertility, associated with anovulation

1.62

0.55

7.3

7.6

—

Dislocation, sprain and strain of joints and ligaments of knee

1.45

0.55

4.9

7.1

—

Superficial injury of wrist and hand

1.54

0.53

8.5

7.7

—

Dermatitis

1.50

0.51

5.2

7.1

—

Any gastric operation

0.71

0.49

7.3

6.5

—

GASTRO-related operations

0.71

0.49

7.2

6.5

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.39

0.48

4.9

6.8

—

Opioids

0.72

0.48

5.1

6.8

—

Abnormalities of breathing

0.69

0.48

5.5

6.4

—

Conjunctivitis (acute, non atopic)

1.52

0.48

6.6

7.1

—

0.68

0.47

4.4

6.9

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

0.68

0.47

4.4

6.9

—

Other abnormal products of conception

1.43

0.47

4.8

7.0

—

Other intervertebral disc disorders

0.57

0.47

2.2

7.6

—

Other diseases of upper respiratory tract

0.71

0.46

6.1

7.0

—

Medical observation and evaluation for suspected diseases and conditions

1.50

0.46

3.5

6.0

—

Gastrointestinal diseases

0.70

0.45

8.8

6.8

—

Chronic apical periodontitis

0.72

0.45

7.8

6.5

—

Mood disorders

0.70

0.45

8.1

6.6

—

Mood [affective] disorders

0.70

0.44

8.1

6.6

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.49

0.44

11.9

6.0

—

Artificial joint operation, meniscal resection

1.68

0.44

7.2

6.5

—

Anxiety disorders

0.70

0.44

5.9

7.0

—

Neurotic, stress-related and somatoform disorders

0.70

0.44

5.9

7.0

—

Other dorsopathies, not elsewhere classified

1.30

0.44

3.9

7.2

—

Cardiac arrhythmias

0.65

0.43

5.3

7.3

—

Gonarthrosis

0.00

0.43

0.0

6.8

—

Impacted teeth

1.39

0.43

5.2

7.0

—

Hard cardiovascular diseases

0.00

0.43

0.0

6.8

—

Injuries to the head

1.29

0.42

6.2

6.6

—

Persons encountering health services for examination and investigation

1.47

0.42

7.5

6.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.64

0.42

2.8

6.9

—

Appendectomy

0.66

0.42

3.5

7.0

—

Diabetic retinopathy

0.00

0.42

0.0

5.6

—

Other degenerative diseases of the nervous system

0.00

0.42

0.0

7.1

—

Allergic conjunctivitis

0.63

0.42

12.2

6.3

—

Other and unspecified dermatitis

1.38

0.41

5.3

7.5

—

Wide developmental disorders, excluding more controls

0.00

0.41

0.0

9.0

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.41

0.0

6.7

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.41

0.0

7.5

—

Mucosal proctocolitis

0.00

0.41

0.0

6.8

—

Insulin, fast-acting (human)

0.00

0.41

0.0

6.9

—

L04AA Selective immunosuppressants

0.00

0.41

0.0

6.9

—

Asthma (only as main-diagnosis), excluding more controls

0.67

0.41

8.6

7.1

—

Asthma (only as main-diagnosis)

0.67

0.41

8.6

7.1

—

Diabetic retinopathy, excluding more controls

0.00

0.41

0.0

5.6

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.41

0.0

6.6

—

Early lumbar disc prolapse, operated

0.00

0.41

0.0

6.1

—

Undetermined asthma

0.00

0.41

0.0

7.7

—

Undetermined asthma, excluding more controls

0.00

0.41

0.0

7.8

—

Spondyloarthritis

0.00

0.41

0.0

6.6

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.41

0.0

6.6

—

Type 1 diabetes, definitions combined

0.00

0.41

0.0

6.6

—

Extrapyramidal and movement disorders

0.00

0.41

0.0

6.6

—

Congenital malformations and deformations of the musculoskeletal system

0.00

0.41

0.0

6.9

—

Caries of dentine

0.00

0.41

0.0

6.9

—

Other septicaemia

0.00

0.41

0.0

6.9

—

Other septicaemia, including avohilmo

0.00

0.41

0.0

6.9

—

Disorders of lacrimal system

1.49

0.40

5.2

7.9

—

ILD medications: azathioprine

0.00

0.40

0.0

6.9

—

Azathioprine

0.00

0.40

0.0

6.9

—

Focal epilepsy

0.00

0.40

0.0

6.8

—

Acute bronchiolitis

0.00

0.40

0.0

6.5

—

Car occupant injured in other and unspecified transport accidents

1.47

0.40

6.0

8.4

—

Dental caries

0.00

0.40

0.0

6.6

—

Pneumonia, organism unspecified

0.66

0.40

4.6

7.2

—

Other headache syndromes

1.33

0.40

2.6

8.1

—

Bitten or struck by other mammals

0.00

0.40

0.0

6.7

—

Acute alcohol intoxication, ICD10

0.00

0.40

0.0

7.1

—

Acute alcohol intoxication

0.00

0.40

0.0

7.1

—

Disease of hard tissues of teeth, NOS

1.45

0.40

7.0

6.3

—

General examination and investigation of persons without complaint and reported diagnosis

1.37

0.39

6.2

6.0

—

Concussion

1.37

0.39

7.1

7.3

—

Asthma, excluding more controls

0.71

0.39

7.6

7.1

—

Bronchitis

1.28

0.39

5.7

6.9

—

Allergic contact dermatitis

0.00

0.39

0.0

8.6

—

Other female pelvic inflammatory diseases

0.00

0.39

0.0

6.2

—

Abdominal and pelvic pain

0.68

0.39

8.4

6.6

—

Excluding asthma or asthma-COPD overlap

0.68

0.39

5.9

7.1

—

Strabismus

1.39

0.38

7.0

7.6

—

Medical treatment for female infertility

1.35

0.38

7.4

6.9

—

Anxiety disorders, excluding more controls

0.68

0.38

6.4

6.8

—

Dental operations

1.54

0.38

8.0

6.7

—

Endocrine, nutritional and metabolic diseases

1.28

0.37

5.9

7.0

—

Migraine

1.31

0.36

3.9

7.4

—

Infections of the skin and subcutaneous tissue

1.39

0.36

3.4

7.6

—

Exposure to other specified factors

1.31

0.36

5.1

6.8

—

Accidents

1.32

0.36

10.4

6.5

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.65

0.35

7.0

7.1

—

Dental pulpitis, including avohilmo

0.75

0.35

7.2

6.5

—

All dysplastic lesions of the cervix uteri

0.66

0.35

7.0

7.1

—

Irregular menses

0.71

0.35

6.1

6.7

—

Neurological diseases, wide definition

1.38

0.35

7.3

7.4

—

Vasomotor and allergic rhinitis

0.63

0.35

6.0

7.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.29

0.35

9.1

6.2

—

Injuries to the ankle and foot

1.30

0.35

5.7

6.7

—

Pain (limb, back, neck, head abdominally)

0.67

0.34

6.0

6.8

—

Disorders of eyelid, lacrimal system and orbit

0.66

0.33

5.2

7.3

—

Embedded and impacted teeth

1.30

0.33

5.5

6.7

—

Covid-19 suspected case

1.30

0.33

7.8

7.4

—

Soft tissue disorders

1.23

0.32

6.7

—

Sciatica+with lumbago

1.35

0.31

2.9

8.3

—

Pain in throat and chest

0.76

0.30

5.9

6.6

—

Asthma (mode)

0.72

0.30

7.6

7.1

—

Asthma

0.71

0.30

7.6

7.1

—

Obesity, other/unspecified

1.27

0.30

3.7

7.8

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

0.76

0.29

6.6

6.5

—

Infections with a predominantly sexual mode of transmission, including avohilmo

0.75

0.29

4.4

6.7

—

Other pulmonary diagnosis

0.76

0.29

7.4

7.1

—

Symptoms and signs involving the digestive system and abdomen

0.76

0.29

9.8

6.6

—

Influenza and pneumonia

0.79

0.28

5.1

6.7

—

Persons encountering health services in other circumstances, wide

1.25

0.28

10.3

6.2

—

Complications of surgical and medical care, not elsewhere classified

0.77

0.28

6.2

6.8

—

Asthma (diagnoses ohter than nonallergic)

0.75

0.27

5.8

6.6

—

Dentofacial anomalies [including malocclusion]

0.74

0.27

4.4

6.8

—

Diabetes mellitus

0.78

0.27

5.6

6.8

—

Other acute lower respiratory infections

1.21

0.26

4.4

7.1

—

Other specific joint derangements/joint disorders

0.79

0.26

5.5

6.6

—

Menorrhagia

1.25

0.26

10.4

7.0

—

Chronic diseases of tonsils and adenoids

0.78

0.26

4.9

7.0

—

Falls/tendency to fall

1.20

0.26

8.9

6.1

—

Antihypertensive medication - note that there are other indications

0.81

0.26

6.0

6.4

—

Arthropathies

0.81

0.25

5.7

6.6

—

Sleep disorders (combined)

0.81

0.25

6.4

6.8

—

Endometriosis

0.71

0.25

11.7

6.7

—

Diabetes, varying definitions

0.80

0.24

5.6

6.7

—

Suppurative and unspecified otitis media

1.25

0.24

5.4

6.9

—

Disorders of breast

0.71

0.24

4.8

7.3

—

Acute tubulo-interstitial nephritis

1.28

0.23

4.2

7.4

—

Dorsalgia

1.19

0.23

3.6

7.2

—

Excessive, frequent and irregular menstruation

1.24

0.23

6.8

6.5

—

Autoimmune diseases

0.83

0.22

6.9

6.7

—

Depression

0.81

0.22

7.6

6.6

—

Inflammatory disease of uterus

1.25

0.22

2.4

7.7

—

Injuries to the knee and lower leg

1.18

0.22

5.3

6.8

—

Major coronary heart disease event

0.00

0.22

0.0

7.0

—

Ischemic heart diseases

0.00

0.22

0.0

7.0

—

Hypothyroidism, strict autoimmune

0.80

0.22

6.6

6.5

—

Non-rheumatic valve diseases

0.00

0.22

0.0

8.9

—

Valvular heart disease excluding rheumatic fever

0.00

0.22

0.0

8.9

—

STROKE

0.00

0.22

0.0

7.1

—

Heart failure, not strict

0.00

0.22

0.0

7.1

—

Other arthrosis

0.00

0.22

0.0

7.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

0.22

0.0

5.9

—

Malignant neoplasm of breast, including Hilmo

0.00

0.22

0.0

5.9

—

Dermatitis due to ingested food

0.00

0.21

0.0

6.8

—

Wide developmental disorders

0.00

0.21

0.0

7.4

—

Gonarthrosis [arthrosis of knee](FG)

0.00

0.21

0.0

6.6

—

0.00

0.21

0.0

7.4

—

Autism

0.00

0.21

0.0

7.4

—

Autism spe, excluding more controls

0.00

0.21

0.0

8.0

—

Agoraphobia

0.00

0.21

0.0

8.0

—

Other juvenile arthritis

0.00

0.21

0.0

7.3

—

Desensitization to allergens

0.00

0.21

0.0

7.4

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.21

0.0

7.3

—

Assault by bodily force

0.00

0.21

0.0

7.9

—

Deep endometriosis

0.00

0.21

0.0

6.5

—

Open wound of forearm

0.00

0.21

0.0

7.3

—

Coeliac disease

0.00

0.21

0.0

7.5

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

6.1

—

Rosacea

0.00

0.21

0.0

5.5

—

Viral pneumonia

0.00

0.21

0.0

7.9

—

Noninfectious colitis NAS

0.00

0.21

0.0

7.5

—

Other inflammation of eyelid

0.00

0.21

0.0

7.9

—

Superficial injury of hip and thigh

0.00

0.21

0.0

8.0

—

Benign paroxysmal vertigo

0.00

0.21

0.0

6.1

—

Other diseases of the digestive system

0.00

0.21

0.0

7.5

—

GI-bleeding

0.00

0.21

0.0

7.5

—

Diseases of liver

0.00

0.21

0.0

7.7

—

Other disorders of urethra and urinary system

0.75

0.21

3.8

7.7

—

Diabetic retinopathy, strict definition

0.00

0.21

0.0

5.6

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

0.21

0.0

7.6

—

Other specified and unspecified personality disorders

0.00

0.21

0.0

7.3

—

Persons encountering health services for specific procedures, not carried out

0.00

0.21

0.0

7.5

—

Open wound of lower leg

0.00

0.21

0.0

10.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.21

0.0

7.8

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.21

0.0

7.3

—

Specific development disorders of scholastic skills

0.00

0.21

0.0

7.1

—

Non-selective monoamine reuptake inhibitors

0.00

0.21

0.0

5.7

—

Pure hypercholesterolaemia

0.00

0.21

0.0

6.4

—

Provisional assignment of new diseases of uncertain etiology

1.25

0.21

7.2

6.8

—

Codes for special purposes

1.25

0.21

7.2

6.8

—

COPD differential diagnosis

0.78

0.21

7.4

7.1

—

ILD differential diagnosis

0.78

0.21

7.4

7.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.25

0.21

7.4

6.5

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

6.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.21

0.0

6.3

—

Spondylopathies (FG)

0.00

0.21

0.0

6.8

—

Fracture of skull and facial bones

0.00

0.21

0.0

5.9

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.21

0.0

6.9

—

Type1 diabetes, definitions combined, early onset

0.00

0.21

0.0

7.0

—

Vocal cord dysfunction

0.00

0.20

0.0

8.7

—

Acute upper respiratory infections

1.20

0.20

6.9

—

Carpal tunnel syndrome

1.27

0.20

6.8

7.3

—

Abnormalities of heart beat

1.26

0.20

9.5

6.6

—

Early lumbar disc prolapse operation

0.00

0.20

0.0

6.8

—

Pruritus

0.00

0.20

0.0

7.1

—

Melanocytic naevi of trunk

0.00

0.20

0.0

6.8

—

Alcohol abuse, main dg

0.00

0.20

0.0

7.6

—

Focal epilepsy, strict definition

0.00

0.20

0.0

6.6

—

Deviated nasal septum

0.00

0.20

0.0

6.7

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.20

0.0

6.8

—

Type 1 diabetes, strict definition

0.00

0.20

0.0

6.8

—

Asthma, hospital admissions , main diagnosis only

0.81

0.20

7.6

6.5

—

Specific development disorders of speech and language

0.00

0.20

0.0

7.4

—

Migraine with aura and triptan purchases

1.22

0.20

5.2

7.1

—

Neurological diseases

1.17

0.20

4.8

7.4

—

Used for control exclusion in common control thyroid runs

0.84

0.19

7.0

6.4

—

Disorders of refraction and accommodation

1.20

0.19

7.0

7.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.17

0.19

4.0

6.0

—

Herpesviral [herpes simplex] infections, including avohilmo

1.18

0.19

10.0

7.5

—

Urticaria

1.18

0.19

3.8

7.4

—

Malaise and fatigue

1.15

0.19

5.3

7.6

—

Congenital malformations, deformations and chromosomal abnormalities

1.21

0.19

4.6

6.8

—

Diseases of middle ear and mastoid

1.19

0.18

4.6

6.8

—

Caries of dentine, including avohilmo

0.73

0.17

8.0

6.3

—

Disorders of conjunctiva

1.18

0.17

8.8

6.2

—

Fever of other and unknown origin

0.76

0.17

5.8

7.5

—

Allergic rhinitis

0.74

0.17

6.0

7.0

—

1.17

0.16

6.0

6.8

—

Constipation

0.78

0.16

5.3

7.6

—

Injury, poisoning and certain other consequences of external causes

1.16

0.16

5.9

6.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.74

0.16

4.2

8.0

—

Dermatophytosis, including avohilmo

1.10

0.16

6.6

7.2

—

Dizziness and giddiness

0.76

0.15

7.8

7.1

—

1.16

0.15

6.8

—

All kidney diseases

0.85

0.15

5.3

6.7

—

Injuries to the shoulder and upper arm

1.10

0.15

5.6

7.1

—

Medical abortion

1.17

0.15

7.1

6.8

—

Childhood allergy (age < 16)

0.81

0.14

7.0

6.7

—

Nonsuppurative otitis media, including avohilmo

0.80

0.14

4.3

6.8

—

Mycoses, including avohilmo

1.16

0.14

7.0

6.5

—

Disorders of skin appendages

0.78

0.14

4.0

7.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.14

0.13

6.9

6.6

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.86

0.12

7.1

6.8

—

Cardiovascular diseases

0.88

0.12

5.9

6.7

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.17

0.12

5.7

7.0

—

Intracranial trauma

1.16

0.12

7.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.86

0.12

7.2

6.7

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.87

0.12

7.8

6.5

—

COPD/asthma/ILD related infections

0.87

0.11

7.9

6.9

—

COPD/asthma related infections

0.87

0.11

7.9

6.9

—

Inflammatory diseases of female pelvic organs

1.13

0.11

5.9

6.7

—

Conjunctivitis

1.14

0.11

9.2

6.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.87

0.10

8.1

6.6

—

Exposure to unspecified factor

1.12

0.10

5.1

6.8

—

Syncope and collapse

1.13

0.10

4.0

8.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.12

0.10

3.2

7.9

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.11

0.09

8.0

7.5

—

Special screening examination for infectious and parasitic diseases

1.07

0.09

7.2

6.0

—

Diabetes medication

0.89

0.09

5.8

6.7

—

Insomnia

1.12

0.09

6.9

6.7

—

Migraine without aura and triptan purchases

1.04

0.09

3.4

7.4

—

Striking against or struck by other objects

1.04

0.09

6.2

7.4

—

Episodal and paroxysmal disorders

1.10

0.09

3.8

7.4

—

Other external causes of accidental injury

1.13

0.09

9.8

6.5

—

Lower back pain or/and sciatica

1.10

0.09

4.2

7.0

—

Unspecified mental disorder

1.09

0.08

3.5

7.3

—

Visual disturbances and blindness

1.09

0.08

4.2

7.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.07

0.08

7.2

—

Allergic asthma (mode)

1.05

0.08

4.2

7.2

—

Allergic asthma (mode), excluding more controls

1.05

0.08

4.2

7.2

—

Open wound of wrist and hand

1.03

0.08

5.7

7.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.03

0.08

7.7

7.4

—

Dysplasia of cervi uteri

0.78

0.08

7.0

6.8

—

Childhood asthma (age<16)

0.77

0.08

9.2

7.0

—

Childhood asthma (age<16), excluding more controls

0.77

0.08

9.2

7.0

—

Hypothyroidism, other/unspecified

0.90

0.08

7.8

6.5

—

Persons encountering health services in other circumstances

1.10

0.08

3.9

6.3

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.04

0.08

4.6

6.5

—

Anaemias

0.85

0.08

12.3

5.7

—

Pain in joint

0.82

0.08

5.7

6.8

—

Genitourinary diseases

1.08

0.08

7.6

7.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

0.80

0.07

4.3

6.9

—

Other soft tissue disorders, not elsewhere classified

1.10

0.07

7.4

6.7

—

Asthma, hospital admission 2, infections

1.07

0.07

6.0

7.0

—

Asthma-related infections

1.07

0.07

6.0

7.0

—

Depression or dysthymia

0.85

0.07

5.0

6.7

—

Atopic dermatitis, strict definition with reimbursement

1.02

0.07

7.5

6.9

—

Acute suppurative otitis media

0.86

0.07

3.3

6.8

—

Other viral diseases, including avohilmo

0.86

0.07

5.6

7.1

—

Other reaction to severe stress, and adjustment disorders

0.85

0.07

3.6

7.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.06

0.07

6.0

7.3

—

Diseases of the respiratory system

0.83

0.07

5.2

7.2

—

Type 2 diabetes, strict (exclude DM1)

1.12

0.07

5.6

7.4

—

Type 2 diabetes, definitions combined

1.12

0.07

5.6

7.4

—

Diseases of the ear and mastoid process

0.92

0.07

7.5

6.5

—

Injuries to the wrist and hand

1.09

0.06

6.3

6.6

—

Other (not insulin) diabetes medications

1.11

0.06

5.6

7.2

—

Gingivitis and periodontal diseases

1.11

0.06

4.8

6.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.90

0.05

7.1

6.8

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.09

0.05

8.5

6.3

—

External causes of morbidity and mortality

1.10

0.04

7.3

6.7

—

Chronic lower respiratory diseases

0.94

0.04

7.5

6.4

—

Diseases of pulp and periapical tissues, including avohilmo

0.93

0.04

6.8

6.5

—

Low back pain

0.93

0.03

4.8

7.2

—

Disorders of the thyroid gland

0.94

0.03

8.2

6.5

—

Parasetamol

0.93

0.02

10.2

6.4

—

Fall on same level

0.95

0.02

5.6

6.7

—

Noninflammatory disorders of female genital tract

1.08

0.02

8.1

6.5

—

Asthma, including avohilmo

1.05

0.02

7.5

6.4

—

Diseases of the eye and adnexa

1.05

0.02

7.4

6.2

—

Type 2 diabetes

0.94

0.02

5.6

7.1

—

Acute upper respiratory infections of multiple and unspecified sites

1.07

0.01

5.3

6.9

—

Biguanides

1.08

0.01

3.7

7.5

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

0.94

0.01

5.5

7.0

—

Other joint disorders

0.96

0.01

5.6

6.6

—

Depression medications

1.07

0.01

10.7

5.7

—

Type 2 diabetes, definitions combined, including avohilmo

1.06

0.00

5.6

7.2

—

Sleep disorders

1.04

0.00

6.3

6.7

—

Renal tubulo-interstitial diseases

1.01

0.00

5.4

7.0

—

Pain in limb

0.99

0.00

7.1

6.7

—

Selective serotonin reuptake inhibitors

0.97

0.00

9.4

6.2

—

Diseases of the musculoskeletal system and connective tissue

1.03

0.00

8.3

7.0

—

Asthma/COPD (KELA code 203)

0.96

0.00

8.4

6.4

—

Symptoms and signs involving the circulatory and respiratory systems

0.97

0.00

8.2

6.4

—

Triptan medication for migraine, min. 3 purchases

1.04

0.00

8.2

6.3

—

Certain infectious and parasitic diseases

0.96

0.00

7.5

6.9

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.0

7.0

—

Volume depletion

0.00

0.0

6.2

—

Other disorders of eyelid

0.00

0.0

7.0

—

Other embolism and thrombosis

0.00

0.0

6.2

—

Certolizumab pegol

0.00

0.0

7.0

—

Dermatophytosis

0.00

0.0

7.0

—

Necrosis of pulp, including avohilmo

0.90

0.00

8.9

6.7

—

Mental and behavioural disorders due to tobacco

0.00

0.0

8.0

—

Other diseases of the respiratory system

0.00

0.0

8.6

—

Implicit bacterial Sepsis, including avohilmo

0.00

0.0

7.0

—

Acute pancreatitis

0.00

0.0

8.0

—

Disorders of vitreous body and globe

0.00

0.0

7.0

—

Use of pramipexole

0.00

0.0

6.2

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.0

7.0

—

Diabetic maculopathy

0.00

0.0

6.7

—

Benign neoplasm of eye and adnexa

0.00

0.0

6.2

—

Bacterial, viral and other infectious agents

0.00

0.0

7.0

—

Maxillary retrognathism

0.00

0.0

6.2

—

Other congenital malformations of ear

0.00

0.0

7.7

—

Sacroiliitis, not elsewhere classified

0.00

0.0

5.0

—

Astigmatism

0.00

0.0

7.7

—

Other or unspecified ileus, impaction or obstruction

0.00

0.0

6.2

—

Other respiratory disorders and diseases

0.00

0.0

8.6

—

Reactive arthropathies

0.00

0.0

7.3

—

Acute pancreatitis (for exclusion)

0.00

0.0

8.0

—

Rash and other nonspecific skin eruption

0.00

0.0

7.0

—

Mandibular retrognathia AND surgery (BSSO)

0.00

0.0

6.3

—

Other inflammation of vagina/vulva

0.00

0.0

6.5

—

Other disorders of cornea

0.00

0.0

6.2

—

Female infertility, tubal origin

0.00

0.0

7.2

—

Golimumab

0.00

0.0

7.7

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.0

5.8

—

Diverticular disease of intestine

0.00

0.0

6.2

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

0.0

6.2

—

Varicella [chickenpox]

0.00

0.0

8.0

—

Diagnoses used for exclusion with ILD

0.00

0.0

7.0

—

Hyperprolactinaemia

0.00

0.0

7.0

—

Juvenile arthritis (FINNGEN)

0.00

0.0

5.6

—

Malignant neoplasm of skin, including Hilmo

0.00

0.0

8.0

—

Monoamine oxidase A inhibitors

0.00

0.0

7.4

—

Benign neoplasm of breast

0.00

0.0

6.3

—

Tic and related disorders

0.00

0.0

7.4

—

Pulmonary heart disease, diseases of pulmonary circulation

0.00

0.0

7.0

—

Viral conjunctivitis, including avohilmo

0.00

0.0

8.0

—

Other and unspecified rosacea

0.00

0.0

7.4

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.0

7.9

—

Lichen sclerosus et atrophicus

0.00

0.0

6.2

—

Other and unspecified drugs and medicaments

0.00

0.0

7.0

—

Hypothyroidism (congenital or acquired)

0.95

0.00

7.6

5.7

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.0

8.0

—

Chronic suppurative otitis media, including avohilmo

0.00

0.0

8.8

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

0.0

7.7

—

Congenital malformations of breast

0.00

0.0

7.0

—

Mental retardation, excluding more controls

0.00

0.0

6.2

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

0.0

7.0

—

Other and unspecified injuries of wrist and hand

0.00

0.0

7.3

—

Agranulocytosis

0.00

0.0

6.2

—

Smoking dependency

0.00

0.0

8.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

7.0

—

Conductive hearing loss, unspecified

0.00

0.0

6.3

—

Ankylosing spondylitis

0.00

0.0

5.4

—

L04AC Interleukin inhibitors

0.00

0.0

7.0

—

Implicit bacterial Sepsis

0.00

-0.00

0.0

7.0

—

Symptoms and signs involving the skin and subcutaneous tissue

0.97

-0.00

6.1

7.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

-0.00

0.0

7.0

—

Other infectious diseases, including avohilmo

0.00

-0.00

0.0

7.0

—

Other viral hepatitis, including avohilmo

0.00

-0.00

0.0

7.0

—

Other viral hepatitis

0.00

-0.00

0.0

7.0

—

Viral infections of the central nervous system, including avohilmo

0.00

-0.00

0.0

7.0

—

Viral meningitis

0.00

-0.00

0.0

7.3

—

Malignant neoplasm of breast

0.00

-0.00

0.0

6.2

—

Implicit fungal Sepsis, including avohilmo

0.00

-0.00

0.0

7.0

—

Spirochaetal infections, other/unspecified

0.00

-0.00

0.0

8.2

—

Varicella [chickenpox], including avohilmo

0.00

-0.00

0.0

7.0

—

Malignant neoplasm of breast, HER2-negative

0.00

-0.00

0.0

6.2

—

Other viral diseases, not elsewhere classified, including avohilmo

0.92

-0.00

5.0

7.5

—

Viral hepatitis

0.00

-0.00

0.0

7.0

—

Viral hepatitis, including avohilmo

0.00

-0.00

0.0

7.0

—

Viral meningitis, including avohilmo

0.00

-0.00

0.0

7.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

6.2

—

Implicit Sepsis, including avohilmo

0.98

-0.00

6.1

7.3

—

Methotrexate

0.00

-0.00

0.0

7.0

—

Allergic colitis

0.00

-0.00

0.0

7.0

—

Collagenous colitis

0.00

-0.00

0.0

8.0

—

Melanocytic naevi of other and unspecified parts of face

0.00

-0.00

0.0

7.0

—

Benign neoplasm of mouth and pharynx

0.00

-0.00

0.0

8.0

—

Immunodeficiencies

0.00

-0.00

0.0

9.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

-0.00

0.0

6.2

—

Hypoglycaemia, other or unspecified

0.00

-0.00

0.0

7.0

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

8.0

—

Conduct disorder

0.00

-0.00

0.0

9.3

—

Anxious personality disorder

0.00

-0.00

0.0

9.0

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

8.0

—

Cluster headache, wide

0.00

-0.00

0.0

8.6

—

Ethmoidectomy

0.00

-0.00

0.0

7.0

—

Organic, including symptomatic, mental disorders

0.00

-0.00

0.0

6.2

—

Schizophrenia

0.00

-0.00

0.0

6.9

—

Mental and behavioural disorders due to cannabinoids

0.00

-0.00

0.0

8.0

—

Pulmonary heart disease

0.00

-0.00

0.0

7.0

—

Cluster headache, strict

0.00

-0.00

0.0

8.6

—

Disorders in reading

0.00

-0.00

0.0

6.2

—

Demyelinating diseases of the central nervous system

0.00

-0.00

0.0

8.4

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

8.0

—

Disorders of speech understanding and production

0.00

-0.00

0.0

6.1

—

FESS (DNB20)

0.00

-0.00

0.0

7.0

—

Cerebral cysts

0.00

-0.00

0.0

7.0

—

Convergent concomitant strabismus

0.00

-0.00

0.0

7.7

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

8.0

—

Lesion of ulnar nerve

0.00

-0.00

0.0

8.0

—

Other CVD

0.00

-0.00

0.0

9.0

—

Chronic suppurative otitis media

0.00

-0.00

0.0

8.7

—

Other and unspecified visual disturbances

0.00

-0.00

0.0

6.4

—

Hypothyroidism, levothyroxine purchases

0.95

-0.00

7.6

5.7

—

Emergency coronary revascularization (for ACS)

0.00

-0.00

0.0

7.7

—

DVT of lower extremities and pulmonary embolism

0.00

-0.00

0.0

8.7

—

Invasive ventilation

0.00

-0.00

0.0

6.2

—

Other chronic obstructive pulmonary disease, including avohilmo

0.00

-0.00

0.0

6.2

—

Intestinal stricture

0.00

-0.00

0.0

8.0

—

Diseases of tongue

0.00

-0.00

0.0

7.6

—

Other gastritis (incl. Duodenitis)

0.00

-0.00

0.0

7.1

—

Dermatitis due to substances taken internally

0.00

-0.00

0.0

6.4

—

Ingrowing nail

0.00

-0.00

0.0

7.4

—

Etanercept

0.00

-0.00

0.0

7.0

—

Urticaria and erythema

1.00

-0.00

3.8

7.2

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

8.8

—

Lichen planus, including avohilmo

0.00

-0.00

0.0

7.0

—

Idiopathic urticaria

0.00

-0.00

0.0

7.3

—

Gonarthrosis,primary

0.00

-0.00

0.0

6.2

—

Disorders of continuity of bone

0.00

-0.00

0.0

7.0

—

Ankylosing spondylitis, ICD10

0.00

-0.00

0.0

8.0

—

Scar conditions and fibrosis of skin

0.00

-0.00

0.0

9.0

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

-0.00

0.0

5.4

—

Recurrent dislocation and subluxation of joint

0.00

-0.00

0.0

7.3

—

Premenstrual syndrome

0.00

-0.00

0.0

7.0

—

Seronegative juvenile rheumatoid arthritis

0.00

-0.00

0.0

7.0

—

Unspecified abortion

0.00

-0.00

0.0

9.0

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

6.9

—

Glomerular disorders in diseases classified elsewhere

0.00

-0.00

0.0

6.2

—

Bilateral sagittal split ramus osteotomy operation

0.00

-0.00

0.0

7.0

—

LeFortI or BSSO operation

0.00

-0.00

0.0

7.0

—

Congenital deformities of feet, including avohilmo

0.00

-0.00

0.0

7.0

—

Congenital deformities of feet

0.00

-0.00

0.0

7.4

—

Congenital malformations of breast, including avohilmo

0.00

-0.00

0.0

7.0

—

Congenital malformations of uterus and cervix

0.00

-0.00

0.0

7.0

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

8.6

—

Abnormalities of gait and mobility

0.00

-0.00

0.0

9.0

—

Elevated blood glucose level

0.00

-0.00

0.0

7.0

—

Lack of expected normal physiological development

0.00

-0.00

0.0

7.8

—

Anti-inflammatory and antirheumatic products, non-steroids

0.93

-0.00

7.4

—

Adalimumab

0.00

-0.00

0.0

5.9

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

7.7

—

L04AD Calcineurin inhibitors

0.00

-0.00

0.0

8.0

—

Abnormal findings on diagnostic imaging of central nervous system

0.00

-0.00

0.0

7.0

—

Polyuria

0.00

-0.00

0.0

6.2

—

Abnormal serum enzyme levels

0.00

-0.00

0.0

7.0

—

Sequelae of injuries of upper limb

0.00

-0.00

0.0

7.0

—

Other general symptoms and signs

0.00

-0.00

0.0

6.3

—

Seropositive rheumatoid arthritis

0.00

-0.00

0.0

7.3

—

Unspecified urinary incontinence

0.00

-0.00

0.0

7.7

—

Other/unspecified seropositive rheumatoid arthritis

0.00

-0.00

0.0

7.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

-0.00

0.0

7.0

—

Contusion of ankle

0.00

-0.00

0.0

7.9

—

Complications of procedures, not elsewhere classified

0.92

-0.00

4.4

7.0

—

Effects of other external causes

0.00

-0.00

0.0

6.3

—

Open wound of abdomen, lower back and pelvis

0.00

-0.00

0.0

9.0

—

Other and unspecified injuries of head

0.00

-0.00

0.0

6.2

—

Diabetic maculopathy, excluding more controls

0.00

-0.00

0.0

7.0

—

Tobacco use

0.00

-0.00

0.0

8.0

—

Other complications of surgical and medical care, not elsewhere classified

0.00

-0.00

0.0

7.0

—

Unspecified privation

0.00

-0.00

0.0

7.0

—

Exposure to other and unspecified animate mechanical forces

0.00

-0.00

0.0

8.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

7.0

—

Exposure to other and unspecified inanimate mechanical forces

0.00

-0.00

0.0

7.7

—

Fall on same level involving ice and snow

0.86

-0.00

12.2

6.7

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

7.0

—

Foreign body entering into or through eye or natural orifice

0.00

-0.00

0.0

7.0

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

7.0

—

Car occupant injured in noncollision transport accident

0.00

-0.00

0.0

7.0

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

6.2

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

8.6

—

Other surgical follow-up care

0.00

-0.00

0.0

7.0

—

Presence of other devices

0.00

-0.00

0.0

7.3

—

Personal history of risk-factors, not elsewhere classified

0.00

-0.00

0.0

8.6

—

Behavioural disorders, excluding more controls

0.00

-0.00

0.0

8.8

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

-0.00

0.0

7.0

—

Atopic dermatitis, strict definition

1.00

-0.00

7.5

6.9

—

Other osteochondropathies

0.00

-0.00

0.0

7.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

8.7

—

Abnormal findings on diagnostic imaging of lung

0.00

-0.00

0.0

7.0

—

Purpura and other haemorrhagic conditions

0.00

-0.00

0.0

6.3

—

Viral infections of the central nervous system

0.00

-0.00

0.0

7.0

—

Unspecified fall

0.94

-0.00

5.8

7.3

—

Hypothyroidism and >3 levothyroxin purchases

0.95

-0.00

7.6

5.7

—

Psoriatic and enteropathic arthropathies

0.00

-0.00

0.0

7.3

—

Vitamin deficiency, wide

0.00

-0.00

0.0

8.6

—

Other disorders of adrenal gland

0.00

-0.00

0.0

8.2

—

Allergic purpura

0.00

-0.00

0.0

9.0

—

Other chronic obstructive pulmonary disease

0.00

-0.00

0.0

6.2

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

-0.00

0.0

6.2

—

Cerebral palsy and other paralytic syndromes

0.00

-0.00

0.0

7.0

—

Malignant neoplasm of skin

0.00

-0.00

0.0

8.0

—

Lichen planus

0.00

-0.00

0.0

9.0

—

Cerebrovascular diseases (FINNGEN)

0.00

-0.00

0.0

7.1

—

Viral hepatitis, IBD co-morbidity

0.00

-0.00

0.0

5.9

—

Autism spe

0.00

-0.00

0.0

8.3

—

Papilloedema, unspecified

0.00

-0.00

0.0

9.0

—

Schizoaffective disorder

0.00

-0.00

0.0

6.3

—

Cervicocranial syndrome

0.00

-0.00

0.0

8.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

0.95

-0.00

2.6

7.4

—

Vitamin deficiency

0.00

-0.00

0.0

8.6

—

Algoneurodystrophy

0.00

-0.00

0.0

8.0

—

Dermatographic urticaria

0.00

-0.00

0.0

5.9

—

Behavioural disorders

0.00

-0.00

0.0

8.2

—

Mixed disorders of conduct and emotions

0.00

-0.00

0.0

8.8

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

8.6

—

Bacterial, viral and other infectious agents, including avohilmo

0.00

-0.00

0.0

7.0

—

Chronic viral hepatitis

0.00

-0.00

0.0

8.0

—

Event of undetermined intent

0.00

-0.00

0.0

7.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.87

-0.00

4.3

7.6

—

Presence of other functional implants

0.00

-0.00

0.0

8.6

—

Lactose intolerance

0.00

-0.00

0.0

7.7

—

Other/unspecified reactive arthropathies

0.00

-0.00

0.0

8.0

—

Symptoms and signs involving the urinary system

0.90

-0.00

4.4

7.9

—

Symptoms and signs involving emotional state

0.00

-0.00

0.0

7.3

—

Implicit Sepsis

0.92

-0.00

3.5

7.6

—

Disorders of lens

0.00

-0.00

0.0

6.2

—

Percutaneous Coronary Intervention

0.00

-0.00

0.0

7.7

—

HSIL lesion of the cervix uteri

0.88

-0.00

7.0

7.7

—

Ovarian cyst

0.99

-0.00

4.9

6.6

—

Lumbar disc prolapse

0.84

-0.00

2.2

8.4

—

Crossbite

0.00

-0.00

0.0

8.1

—

Hernia

0.88

-0.00

6.0

7.7

—

Other hearing loss

0.00

-0.00

0.0

8.0

—

Nontoxic multinodular goitre

0.00

-0.00

0.0

8.0

—

DVT of lower extremities

0.00

-0.00

0.0

8.0

—

Cholecystitis

0.00

-0.00

0.0

8.6

—

Other disorders of fluid, electrolyte and acid-base balance

0.00

-0.00

0.0

7.0

—

Disorders of other endocrine glands

0.92

-0.00

2.7

7.1

—

Disorders of synovium and tendon

0.92

-0.00

2.2

7.2

—

Visual disturbances

1.00

-0.00

4.0

7.3

—

Sudden idiopathic hearing loss

0.00

-0.00

0.0

6.2

—

Nasal polyp

0.00

-0.00

0.0

6.5

—

Inflammatory diseases of the central nervous system

0.00

-0.00

0.0

8.0

—

Restless leg syndrome

0.00

-0.00

0.0

7.0

—

malignant neoplasm of female genital organs, including Hilmo

0.00

-0.00

0.0

6.2

—

Malignant melanoma, including Hilmo

0.00

-0.00

0.0

8.6

—

Other infectious diseases

0.00

-0.00

0.0

9.0

—

Pediculosis, acariasis and other infestations

0.00

-0.00

0.0

7.7

—

Scabies

0.00

-0.00

0.0

7.7

—

Suggestive for eosinophilic asthma

0.00

-0.00

0.0

6.2

—

Autoimmune hepatitis, wide definition

0.00

-0.00

0.0

8.2

—

Migraine with aura

0.89

-0.00

5.2

8.0

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

5.4

—

Bell's palsy

0.00

-0.00

0.0

7.0

—

Pilonidal cyst

0.00

-0.00

0.0

7.1

—

Other (seronegative) rheumatoid arthritis, wide

0.00

-0.00

0.0

8.0

—

Viral pneumonia (unknown virus, not influenza)

0.00

-0.00

0.0

7.0

—

Mixed specific developmental disorders

0.00

-0.00

0.0

8.2

—

Gender identity disorders

0.00

-0.00

0.0

7.4

—

Mixed and other personality disorders

0.00

-0.00

0.0

6.6

—

Other diseases of blood and blood-forming organs, wide

0.00

-0.00

0.0

8.8

—

Certain disorders involving the immune mechanism

0.00

-0.00

0.0

7.0

—

Diabetic nephropathy, excluding more controls

0.00

-0.00

0.0

7.1

—

Glaucoma

0.00

-0.00

0.0

7.0

—

COPD

0.00

-0.00

0.0

6.2

—

Other diseases of liver

0.00

-0.00

0.0

8.0

—

Plantar fascial fibromatosis

0.00

-0.00

0.0

5.4

—

Vasomotor rhinitis (mode)

0.00

-0.00

0.0

9.0

—

Toxic effect of ethanol

0.00

-0.00

0.0

6.4

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

7.0

—

Ulcerative ileocolitis

0.00

-0.00

0.0

6.2

—

Other ulcerative colitis

0.00

-0.00

0.0

7.7

—

Nonspecific lymphadenitis

0.00

-0.00

0.0

7.0

—

Hypoplasia of dental enamel , including avohilmo

0.00

-0.00

0.0

8.8

—

Paralytic ileus and intestinal obstruction

0.00

-0.00

0.0

7.0

—

Intestinal malabsorption

0.00

-0.00

0.0

7.7

—

Molar incisor enamel hypoplasia

0.00

-0.00

0.0

8.8

—

Mandibular retrognathia

0.00

-0.00

0.0

6.3

—

Atrophic disorders of skin

0.00

-0.00

0.0

6.4

—

Flat foot [pes planus] (acquired)

0.00

-0.00

0.0

7.3

—

Coronary revascularization (ANGIO or CABG)

0.00

-0.00

0.0

7.7

—

Stroke, excluding SAH

0.00

-0.00

0.0

7.3

—

Stroke, including SAH

0.00

-0.00

0.0

7.0

—

Unspecified acute lower respiratory infection

0.00

-0.00

0.0

7.0

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

6.2

—

Other and unspecified tonsillitis

0.91

-0.00

4.8

6.8

—

Diabetic nephropathy

0.00

-0.00

0.0

5.2

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

-0.00

0.0

7.0

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.00

-0.00

0.0

8.0

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

-0.00

0.0

8.8

—

Psoriatic arthropathies

0.00

-0.00

0.0

8.6

—

Spondylosis

0.00

-0.00

0.0

6.8

—

Other specified/unspecified inflammatory spondylopathies

0.00

-0.00

0.0

5.4

—

Benign mammary dysplasia

0.00

-0.00

0.0

7.3

—

Chronic kidney disease

0.00

-0.00

0.0

6.2

—

Endometriosis of intestine

0.00

-0.00

0.0

6.4

—

HSIL lesion of the cervix uteri, vagina or vulva

0.85

-0.00

7.0

7.6

—

Glomerular diseases

0.00

-0.00

0.0

7.0

—

Glomerulonephritis

0.00

-0.00

0.0

7.0

—

Glaucoma suspect

0.00

-0.00

0.0

7.0

—

Pulmonary embolism

0.00

-0.00

0.0

7.0

—

Transient ischemic attack

0.00

-0.00

0.0

6.2

—

Abscess of anal and rectal regions

0.00

-0.00

0.0

7.0

—

Chronic gastritis

0.00

-0.00

0.0

6.2

—

Hypertrophic scar

0.00

-0.00

0.0

8.8

—

Perioral dermatitis

0.00

-0.00

0.0

7.4

—

Fibroblastic disorders

0.00

-0.00

0.0

5.4

—

Seropositive rheumatoid arthritis, wide

0.00

-0.00

0.0

7.0

—

Juvenile rheumatoid arthirtis

0.00

-0.00

0.0

8.2

—

Reactive arthropathies, FINNGEN

0.00

-0.00

0.0

7.3

—

Seropositive rheumatoid arthritis, strict definition

0.00

-0.00

0.0

6.2

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

6.2

—

Melanocytic naevi, other sites/unspecified

0.00

-0.00

0.0

7.9

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

-0.00

0.0

9.0

—

Crohn's disease of large intestine

0.00

-0.00

0.0

8.0

—

Other Crohn's disease

0.00

-0.00

0.0

6.3

—

Migraine without aura

0.98

-0.00

3.7

8.0

—

MS-disease / Multiple Sclerosis

0.00

-0.00

0.0

8.4

—

Generalized epilepsy

0.00

-0.00

0.0

7.0

—

Ankyloglossia

0.00

-0.00

0.0

8.2

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

0.00

-0.00

0.0

9.0

—

Prominent ears

0.00

-0.00

0.0

7.7

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

6.2

—

Postpartum haemorrhage due to anatomy

0.93

-0.00

10.4

6.8

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

-0.00

0.0

8.2

—

Ischaemic heart disease, wide definition

0.00

-0.00

0.0

6.2

—

Hypopituitarism

0.00

-0.00

0.0

6.2

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

7.7

—

Other and unspecified coagulation defects

0.00

-0.00

0.0

7.0

—

Residual foreign body in soft tissue

0.00

-0.00

0.0

5.4

—

Disorders of vitreous body

0.00

-0.00

0.0

7.0

—

Optic neuritis

0.00

-0.00

0.0

7.0

—

Other otitis externa (chronic)

0.00

-0.00

0.0

8.6

—

Renal failure

0.00

-0.00

0.0

7.0

—

Ulcer of vagina/vulva

0.00

-0.00

0.0

7.0

—

Benign neoplasm of bone and articular cartilage

0.00

-0.00

0.0

7.0

—

Disorders of optic nerve and visual pathways

0.00

-0.00

0.0

6.9

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bacteria [#/volume] in Mother's milk

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS